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 ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not ginger 
is a safe and effective treatment for moderate or severe dysmenorrhea in females over the age of 
18.  
 
STUDY DESIGN: Review of three randomized controlled studies. All three studies are 
published in English between 2009-2013. 
 
DATA SOURCES: Three randomized placebo controlled studies  found using PubMed and 
Medline.  
 
OUTCOMES MEASURED: The outcomes that were measured were severity of pain, duration 
of pain, change in symptoms, and change in severity.  This was done by using a visual analogue 
scale, 5-point Likert scale, Wilcoxon’s rank-sum test, and verbal multidimensional scoring 
system.  
 
RESULTS: The first study, the Jenabi study showed that 29 subjects, 82.85%,  reported 
improvement in their dysmenorrhea symptoms compared to 16 subjects, 47.05%, in the placebo 
group determined by the five-point Likert scale. In the second study, Ozgoli et al study showed 
that 62% of subject showed improvement using ginger capsules via a verbal multidimensional 
scoring system, as compared to 66% of patients using ibuprofen respectively. The third study,  
Rahnama et al study showed that the ginger group reported 11 hours less pain duration  as well 
as 3 cm less in severity of pain than the placebo group, measured by verbal multidimensional 
scoring system and visual analogue scale. No serious adverse events were noted in any of the 
three studies.  
 
CONCLUSIONS: Based on these three trials, ginger is a safe and effective treatment for 
moderate or severe dysmenorrhea. Each study showed improvement of symptoms or showed it to 
be as effective as NSAIDs without any serious side effects when using ginger.  
 
KEY WORDS: Ginger, dysmenorrhea 
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INTRODUCTION 
 Dysmenorrhea, also commonly referred to as menstrual cramps, can be characterized as 
throbbing or cramping pains in the lower abdomen that can radiate to the inner thighs just before 
or during a woman’s menstrual cycle with no identifiable pathologic lesion.1,5 It is considered 
moderate or severe when a woman has either moderate or severe pain with influence on daily 
activities, ineffective use of analgesics, and symptoms such as headache, tenderness, nausea, 
vomiting, and diarrhea. 5 This paper evaluates three double blind, randomized controlled trials 
comparing the efficacy of ginger as an oral medication compared to a placebo or NSAID for 
improving moderate or severe dysmenorrhea in females over the age of 18.  
 Dysmenorrhea is relevant to the Physician Assistant profession due to its prevalence, cost 
to the patients, and amount of lost time from school and work. Dysmenorrhea can have 
significant effects on patients quality of life. It is extremely common, being one of the most 
frequent gynecologic disorders, affecting more than half of menstruating women. 3 There is an 
estimation that severe dysmenorrhea results in a loss of 600 million working hours and 
approximately two billion dollars in lost productivity. 2,4 The exact number of health care visits 
due to dysmenorrhea is unknown, however approximately 45.6% of women with severe 
dysmenorrhea are absent from school or work, resulting in a need for a physician visit and 
excuse, which is why it is so important for medical providers to aware of this problem. 4 
 The exact etiology of the dysmenorrhea is unknown; however, the symptoms are thought 
to be associated with increased production of prostaglandins in the endomentrium which causes 
increased myometrial contractility, uterine ischemia, and sensitizations of pain fibers.4,5 Due to 
the unknown exact etiology, there is currently no curative treatment.  
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 In most cases of dysmenorrhea, nonsteroidal anti-inflammatory drugs (NSAIDs) are the 
usual first line therapy.6  As the suggested etiology of dysmenorrhea is due to the excess 
production of prostaglandins, the use of NSAIDs would cause inhibition of prostaglandin 
synthesis, relieving women of dysmenorrhea.6  However, previous studies have showed that up to 
25% of women fail the conventional therapy of NSAIDs or may also have contraindications to 
the use of NSAIDs.6  Other methods that are commonly used for dysmenorrhea are combined 
oral contraceptives. These hormones act by suppressing ovulation and lessening the endometrial 
lining of the uterus, which in end decrease the amount of prostaglandins. 7 However, due to 
many contraindications of the use of combined oral contraceptive pills, such as history of deep 
venous thrombosis or family history of coagulopathies, some women may not be able to use 
them as treatment for their dysmenorrhea. Due to the failure rate, limited efficacy, and 
contraindications of NSAIDs and combined oral contraceptives, the use of ginger may be used as 
an oral alternative for the relief of dysmenorrhea.  
OBJECTIVE 
 The objective of this systematic review is to determine whether or not ginger is an 
effective treatment for moderate or severe dysmenorrhea in females over the age of 18.  
METHODS 
 All three studies used in this review required a population of females greater than the age 
of 18 years old with moderate to severe dysmenorrhea. The intervention was the implementation 
of ginger tablets, 250 mg or 500 mg, taken three times or four times a day. Comparisons were 
made between subjects that took a ginger tablet and experimental groups who either took a 
placebo or ibuprofen. The outcomes measured were severity of pain, duration of pain, and 
change in severity. All three studies were randomized controlled trails (RCTs) that evaluated 
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ginger as an effective treatment for moderate or severe dysmenorrhea in females 18 years or 
older.  
 Keywords used when searching for articles consisted of ginger and dysmenorrhea, all of 
which were in English and in peer-reviewed journals. The articles chosen were researched by the 
author and obtained through either PubMed, Medine, OVID, or Google Scholar. The articles 
were selected based on the types of studies, the relevance to the clinical question being asked and 
that the outcomes of the studies mattered to patients. Inclusion criteria for selecting these articles 
included randomized controlled studies that directly benefit the patient. Exclusion criteria 
included patients under the age of 18 years old. The statistics that were utilized and reported 
included relative benefit increase (RBI), absolute benefit increase (ABI), relative risk increase 
(RRI), absolute risk increase (ARI), numbers needed to treat (NNT), numbers needed to harm 
(NNH), and p-value.  Table 1 displays the demographics and characteristics of the included 
studies.  
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Table 1- Demographics & Characteristics of included studies 
Study Type # of 
Pts 
Age 
(yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Jenabi4 
(2013) 
RCT 70 ≥ 18 
years 
old 
Patients ≥ 18 
years old that 
had moderate 
to severe 
dysmenorrhea 
Cases of mild 
dysmenorrhea 
1 500 mg of 
Ginger TID 
for first 3 
days of 
menstruation 
Ozgoli et 
al 5 
(2009) 
Double 
blind 
RCT 
150 ≥ 18 
years 
old 
Patients ≥ 18 
years old that 
had moderate 
to severe 
dysmenorrhea 
Pre-existing 
diagnosed 
disease, 
history of 
gestation or 
taking oral 
contraceptives, 
medicinal or 
herbal 
sensitivities, 
BMI <19 or 
>26, and mild 
dysmenorrhea 
0 250 mg of 
Ginger QID 
for first 3 
days of 
menstruation 
Rahnama 
et al 6 
(2012) 
Double 
blind 
RCT 
120 ≥ 18 
years 
old 
Patients ≥ 18 
years old that 
had moderate 
to severe 
dysmenorrhea; 
being single, 
having a 
menstrual 
cycle that last 
from 21 to 35 
days with 2-6 
days of flow 
and average 
blood loss of 
20-60 ml.  
Diagnosis of a 
disease, a 
history of 
pregnancy or 
taking oral 
contraceptives, 
BMI <19 or 
>25, and mild 
dysmenorrhea 
15 500 mg of 
Ginger TID 
for first 3 
days of 
menstruation 
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OUTCOMES MEASURED 
 In Rahnama et al study, the outcomes that were measured were the severity of pain and 
duration of pain. The way they were measured were by using a verbal multidimensional scoring 
system, visual analogue scale, and ANCOVA. In Jenabi’s study, the outcomes that were 
measured were severity of pain and change in symptoms, which were measured by a visual 
analgoue, 5-point Likert scale, and Wilcoxon’s rank-sum test. In the Ozgoli et al study, the 
outcome that was measured was change in pain severity, which was measured by using a verbal 
multidimensional scoring system and 5-point Likert-scale.  
RESULTS 
 All three articles compared the use of ginger with the use of a placebo or ibuprofen for 
the treatment of moderate or severe dysmenorrhea. Each article consisted of three randomized 
controlled trails, all presented in continuous data which were then converted into dichotomous 
data.  
 The Jenabi study excluded females that had mild dysmenorrhea. The subjects took either 
a 500mg tablet of ginger TID or a placebo TID, depending on the group they were blindly placed 
in. This study showed that compared to the baseline, the ginger group had a notably greater 
reduction in pain compared to that of the placebo group, measure by visual analogue.4 The 
change in pain scores are listed in Table 2, while the change in symptoms is listed in Table 3. 
The change in pain score was greater in the ginger group at 3.81±1.17, while the placebo change 
in pain score was only 0.48±0.91, with a p-value of 0.001, showing true significance.  
Approximately 83% of subjects in the ginger group reported improvement in symptoms while 
only 47% of the placebo group reported improvement in symptoms. The relative benefit increase 
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(RBI) was 77.6%, the absolute benefit increase (ABI) was 36.1%, and the numbers needed to 
treat (NNT) was 3, all of which point to this being a large treatment effect. 
Table 2. Change in Pain Score for Jenabi Study.4  
Type of Treatment Before Use 
(Mean±SD) 
After Use (Mean±SD) Before use- after use 
Ginger 7.08 ± 1.02 4.81 ± 1.70 3.81 ± 1.17 
Placebo 7.61 ± 1.20 7.11 ± 1.12 0.48 ± 0.91 
p-value 0.61 0.001 0.001 
 
Table 3. Change in symptoms for Jenabi Study.4  
Change in Symptoms Ginger Placebo 
Much worse 0 0 
Worse 0 0 
Same 6 (17.4%) 18 (53.5%) 
Better 14 (40.0%) 10 (29.0%) 
Much Better 15 (42.6%) 6 (17.5%)  
n 35 34 
 
 Ozgoli et al study excluded females with pre-existing diagnosed disease, history of 
gestation or taking oral contraceptives, medicinal or herbal sensitivities, BMI <19 or >26, and 
mild dysmenorrhea.5 The subjects took either 250 mg of ginger QID or 400 mg of ibuprofen QID 
for the first three days of the menstrual cycle. This study showed that ginger was an as effective 
treatment as ibuprofen (NSAID) in the fact that both groups had a decrease in the severity of 
dysmenorrhea with no differences between the groups in severity of dysmenorrhea, pain relief, 
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or satisfaction with treatment.5  In the group taking ibuprofen, 66% of the subjects said that their 
pain was either relieved or considerably relieved. In the ginger group, 62% of the subjects said 
that their pain was either relieved or considerably relieved. Table 4 shows the change in pain 
severity for both the ibuprofen and ginger groups. The RBI was -6.1%, the ABI was -4% and the 
NNT was -25, all of which point to a large treatment effect.  
Table 4. Change in pain severity for Ozgoli et al.5 
Change in Pain Severity Ibuprofen Ginger 
Considerably relieved 18 (36%)  18 (36%) 
Relieved 15 (30%) 13 (26%) 
Unchanged 17 (34%) 15 (30%) 
Worse 
 
3 (6%) 4 (8%) 
Considerably worse 0 0 
 
 Rahnama et al study excluded subjects based on diagnoses of a disease, a history of 
pregnancy or taking oral contraceptives, BMI <19 or >25, and mild dysmenorrhea.6  The subjects 
took either 500 mg of ginger TID or a placebo TID for the first three days of the menstrual cycle. 
There was two different protocols that were done, but for this paper we will focus on protocol 2 
which consisted of either 500 mg of ginger TID or a placebo TID given for the first three days of 
the menstrual period. This study showed that there was a noteworthy difference in severity of 
pain between ginger and the placebo groups (p=0.008), however there was not a significant 
change in the duration of pain (p=0.080) .6  The ginger group reported a 2.72 ± 2.82 change in 
severity of pain from before and after use, while the placebo group reported a 1.51 ± 2.77 change 
in severity of pain from before and after use.6  Table 5 and Table 6 show the change in pain 
severity and duration of pain between the ginger and placebo group. The relative risk increase 
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(RRI) was -41%, the absolute risk increase (ARI) is -3.6% and the numbers needed to harm 
(NNH) was 27, all of which point to a large treatment effect.  
Table 5. Change in severity of pain for Rahnama et al study. 6 
 Before Use 
(Mean±SD) 
After Use 
(Mean±SD) 
Before use- after 
use 
p-value 
Ginger 7.34 ± 1.1 4.61 ± 2.55 2.72 ± 2.82 
0.008 
Placebo 7.52 ± 0.93 6.01 ± 2.65 1.51 ± 2.77 
 
Table 6. Change in duration of pain for Rahnama et al study. 6 
 Before Use 
(Mean±SD) 
After Use 
(Mean±SD) 
Before use- after 
use 
p-value 
Ginger 19.38 ± 16.35 10.88 ± 14.54 8.50 ± 17.77 
0.080 
Placebo 19.06 ± 22.73 15.57 ± 14.72 3.48 ± 23.08 
 
DISCUSSION 
 Ginger is a complex herb that is essentially made up of sesquiterpene, but also includes 
carbohydrates, free fatty acids, amino acids, proteins, phytoesterols, niacin, and nonaromatic 
compounds. 5, 8 It has been found that ginger inhibits cyclooxygenase and lipoxygenase pathways 
in the prostaglandin pathway synthesis as well as have anti-inflammatory effects, which is why 
they believe ginger improves females dysmenorrhea. 5,6 Ginger has also been found to help in 
other problems including dyspepsia, colic, vomiting, diarrhea, colds, influenza, arthritis, kidney 
stones, and asthma. 4,5 
 All three studies analyzed showed a greater improvement in dysmenorrhea with the use 
of ginger compared to the use of placebo and was consider as adequate as ibuprofen. This review 
supports the use of ginger in the treatment of dysmenorrhea but there are some limitations in the 
studies used. Both Rahnama et al and Ozgoli et al studies both made distinct points with the lack 
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of observation regarding the effects on ginger on the other symptoms that are linked to 
dysmenorrhea such as nausea, vomiting, etc. 5,6 Furthermore, in the Rahnama et al study, 13 
patients from the placebo group had left the study and no data was available from them. In all 
three studies there is a strong indication that there is a limitation on the physiology of why ginger 
helps with improvement of dysmenorrhea. There is a strong suggestion that in order to expand 
our knowledge and understanding of why ginger works to improve dysmenorrhea, further studies 
need to be done, as well as knowing the exact etiology of dysmenorrhea.  
CONCLUSION 
 Based on this systematic review and chosen studies, ginger is an effective treatment for 
moderate or severe dysmenorrhea. The data within these three studies are consistent with the 
beneficial effects of ginger as well as its overall safety. No serious adverse effects were noted in 
any of the studies. Therefore it should be considered by healthcare providers to recommend to 
patients as a treatment of moderate or severe dysmenorrhea. Additional studies investigating  the 
effects of ginger on other symptoms associated with dysmenorrhea, the safety of various doses of 
ginger, and the exact mechanism of action of ginger should be considered. 4,5,6 
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